Ticker: MGRX

Telehealth player Mangoceuticals partners with Eli Lilly and Novo Nordisk, launching digital programs to sell blockbuster GLP-1 weight-loss drugs, sparking a 32% jump in its shares.

Mangoceuticals, Inc. (NASDAQ: MGRX) Company Overview: Mangoceuticals, Inc. focuses on men’s wellness products delivered through a telemedicine platform, including brands targeting erectile dysfunction and hair loss. The company is conducting clinical trials for respiratory illness prevention tech...